The DGFT vide Public Notice No. 46 / 2024-25 dated February 06, 2025, has issued amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.
In exercise of the powers conferred under paragraphs 1.03 and 2.04 of the Foreign Trade Policy-2023 as amended from time to time, the Director General of Foreign Trade makes the following amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet.
| Export Product | Quantity | SI. No. | Import Item/s | Quantity |
| Erythromycin Stearate tablets – 250 mg. (each tablet contains erythromycin stearate equivalent to 250 mg. of Erythromycin) | 1 Number Tablet | 1 | Erythromycin
Stearate |
334 mg. |
Note: For other variants of export items, norms may be worked out on a pro-rata basis.
Effect of the Public Notice: Standard Input Output Norm appearing under A-222 is amended as above with immediate effect.
The Public Notice can be accessed at: https://a2ztaxcorp.net/wp-content/uploads/2025/02/Public-Notice-no.-46-Eng.pdf
